These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 205742

  • 21. A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma.
    Van Loon GR.
    Lancet; 1978 Oct 21; 2(8095):868-71. PubMed ID: 81414
    [Abstract] [Full Text] [Related]

  • 22. Bromocriptine reduction of prolactinoma size.
    Corenblum B, Hanley DA.
    Fertil Steril; 1981 Dec 21; 36(6):716-9. PubMed ID: 7308514
    [Abstract] [Full Text] [Related]

  • 23. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
    Saitoh Y, Koizumi K, Arita N, Hayakawa T, Mogami H, Matsumoto K, Mori H.
    Anticancer Res; 1986 Dec 21; 6(5):1149-55. PubMed ID: 3800323
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
    Canales ES, García IC, Ruíz JE, Zárate A.
    Fertil Steril; 1981 Oct 21; 36(4):524-6. PubMed ID: 7286276
    [No Abstract] [Full Text] [Related]

  • 27. Bromocriptine-induced removal of endoplasmic membranes from prolactinoma cells.
    Landolt AM, Osterwalder V, Landolt TA.
    Experientia; 1985 May 15; 41(5):640-2. PubMed ID: 3996537
    [Abstract] [Full Text] [Related]

  • 28. Management of prolactinomas--1986.
    Tan SL, Jacobs HS.
    Br J Obstet Gynaecol; 1986 Oct 15; 93(10):1025-9. PubMed ID: 3790461
    [No Abstract] [Full Text] [Related]

  • 29. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
    Niwa J, Sato O, Tanabe S.
    Comput Radiol; 1983 Oct 15; 7(4):237-41. PubMed ID: 6641185
    [Abstract] [Full Text] [Related]

  • 30. Prolactinoma of the pituitary containing amyloid.
    Paetau A, Partanen S, Mustajoki P, Valtonen S, Pelkonen R, Wahlström T.
    Acta Endocrinol (Copenh); 1985 Jun 15; 109(2):176-80. PubMed ID: 3893008
    [Abstract] [Full Text] [Related]

  • 31. Acidophil stem cell adenoma of the human pituitary.
    Horvath E, Kovacs K, Singer W, Ezrin C, Kerenyi NA.
    Arch Pathol Lab Med; 1977 Nov 15; 101(11):594-9. PubMed ID: 199135
    [Abstract] [Full Text] [Related]

  • 32. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M, Muhr C, Lundberg PO, Bergström K, Gee AD, Fasth KJ, Långström B.
    J Comput Assist Tomogr; 1987 Nov 15; 11(5):815-9. PubMed ID: 3498743
    [Abstract] [Full Text] [Related]

  • 33. Prolactin-secreting pituitary oncocytoma with galactorrhea--amenorrhea syndrome: a histologic, ultrastructural, and immunocytochemical study.
    Kalyanaraman UP, Halmi NS, Elwood PW.
    Cancer; 1980 Oct 01; 46(7):1584-9. PubMed ID: 7191348
    [Abstract] [Full Text] [Related]

  • 34. Dopaminergic treatment of nonfunctioning pituitary adenomas.
    Greenman Y.
    Nat Clin Pract Endocrinol Metab; 2007 Aug 01; 3(8):554-5. PubMed ID: 17579584
    [No Abstract] [Full Text] [Related]

  • 35. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
    Archer DF, Lattanzi DR, Moore EE, Harger JH, Herbert DL.
    Am J Obstet Gynecol; 1982 Jul 15; 143(6):620-5. PubMed ID: 7201244
    [Abstract] [Full Text] [Related]

  • 36. Regression of pituitary prolactinoma after treatment with bromocriptine.
    Landolt AM, Wüthrich R, Fellmann H.
    Lancet; 1979 May 19; 1(8125):1082-3. PubMed ID: 86800
    [No Abstract] [Full Text] [Related]

  • 37. Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas.
    Zárate A, Morán C, Klériga E, Loyo M, González-Angulo A, Aquilar-Parada E.
    Acta Endocrinol (Copenh); 1985 Apr 19; 108(4):445-50. PubMed ID: 3993311
    [Abstract] [Full Text] [Related]

  • 38. [New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma].
    Geyer G.
    Wien Med Wochenschr; 1980 Aug 31; 130(15-16):501-9. PubMed ID: 6258331
    [No Abstract] [Full Text] [Related]

  • 39. Pituitary carcinoma: an ultrastructural study of eleven cases.
    Scheithauer BW, Fereidooni F, Horvath E, Kovacs K, Robbins P, Tews D, Henry K, Pernicone P, Gaffrey TA, Meyer FB, Young WF, Fahlbusch R, Buchfelder M, Lloyd RV.
    Ultrastruct Pathol; 2001 Aug 31; 25(3):227-42. PubMed ID: 11465479
    [Abstract] [Full Text] [Related]

  • 40. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
    Felix IA, Horvath E, Kovacs K, Smyth HS, Killinger DW, Vale J.
    Acta Neuropathol; 1986 Aug 31; 71(1-2):76-82. PubMed ID: 3776476
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.